Skinvisible (SKVI) EV to EBITDA (2010 - 2026)
Skinvisible's (SKVI) quarterly EV to EBITDA came in at 10.02 in Q2 2026, up 6.4% year-over-year from 9.42 in Q2 2025, and up 2.53% quarter-over-quarter from 10.28 in Q1 2026.
Powered by 
Analysis
Skinvisible (SKVI) EV to EBITDA (2010 - 2026) Analysis & Trends
Skinvisible has disclosed EV to EBITDA across 17 years of filings, most recently posting 10.02 for Q2 2026.
- In Q2 2026, EV to EBITDA rose 6.4% year-over-year to 10.02; the TTM figure through Jun 2026 stood at 2.46 (down 1.29% YoY), while the FY2025 annual figure was 2.5, up 18.03% from the prior year.
- EV to EBITDA came in at 10.02 for Q2 2026 at Skinvisible, up from 10.28 in the prior quarter.
- In the past five years, EV to EBITDA ranged from a high of 4.47 in Q2 2022 to a low of 25.65 in Q2 2024.
- Average EV to EBITDA over 5 years is 8.64, with a median of 7.37 recorded in 2022.
- Year-over-year, EV to EBITDA jumped 88.26% in 2022 and tumbled 787.62% in 2025.
- Over 5 years, EV to EBITDA stood at 3.17 in 2022, then increased by 16.17% to 2.65 in 2023, then plunged by 240.83% to 9.04 in 2024, then retreated by 20.12% to 10.86 in 2025, then advanced by 7.73% to 10.02 in 2026.
- Per Business Quant data, the three most recent EV to EBITDA figures were 10.02 in Q2 2026, 10.28 in Q1 2026, and 10.86 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.23 Bn | 627.47 Bn | 17.26 Bn |
| 2 | AbbVie | 443.69 Bn | 437.12 Bn | 12.70 Bn |
| 3 | Merck | 368.29 Bn | 361.15 Bn | 12.21 Bn |
| 4 | Novartis Ag | 270.18 Bn | 262.49 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.93 Bn | 45.55 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.15 Bn | 44.15 Bn | - |
| 8 | Incyte | 25.21 Bn | 20.68 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.11 Bn | 18.44 Bn | 683.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.02 |
| Mar 31, 2026 | -10.28 |
| Dec 31, 2025 | -10.86 |
| Sep 30, 2025 | -7.64 |
| Jun 30, 2025 | -10.71 |
| Mar 31, 2025 | -22.32 |
| Dec 31, 2024 | -9.04 |
| Sep 30, 2024 | -23.47 |
| Jun 30, 2024 | -25.65 |
| Mar 31, 2024 | -2.51 |
| Dec 31, 2023 | -2.65 |
| Sep 30, 2023 | -2.80 |
| Jun 30, 2023 | -3.99 |
| Mar 31, 2023 | -2.61 |
| Dec 31, 2022 | -3.17 |
| Sep 30, 2022 | -5.07 |
| Jun 30, 2022 | 4.47 |
| Mar 31, 2022 | -7.10 |
| Dec 31, 2021 | 6.94 |
| Sep 30, 2021 | -43.16 |